Fingerprint
Dive into the research topics of 'Trametinib dimethyl sulfoxide. MAP kinase kinase 1 and 2 (MEK 1/2) inhibitor oncolytic'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
D. P. Cosgrove
Research output: Contribution to journal › Review article › peer-review